Align Technology stock gains institutional support as fundamentals hold steady
Published on 09/08/2026 at 15:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Align Technology stock (ISIN US0162551016) is quoted at USD 158.63 on Nasdaq as of a recent session, with the shares trading between a 52-week low of USD 122.00 and a high of USD 200.43 according to market data as of early September 2026.MarketBeat For investors, the combination of a stable fundamental picture and fresh institutional inflows is currently shaping sentiment around the Tempe-based dental technology specialist.
Institutional buying and analyst targets support the stock
One of the latest signals for Align Technology stock is a sizable position increase by Parkside Financial Bank & Trust, which lifted its holdings by 1,125.1 percent in the second quarter of the current year according to a regulatory filing summarized by MarketBeat. The institution added 9,327 shares, bringing its stake to 10,156 shares valued at USD 1.713 million as of the end of that reporting period, indicating growing confidence from at least one mid-sized financial player.
Other institutional investors highlighted in the same overview have also adjusted their exposure, contributing to an institutional ownership level of 88.43 percent of Align Technology’s shares.MarketBeat This high ownership share can be relevant for retail investors: institutional investors tend to respond quickly to changes in earnings trends or guidance, and their trading activity often amplifies price moves around new information.
Fundamentals: recent quarter and valuation metrics
According to the latest earnings coverage compiled by MarketBeat, Align Technology reported revenue of USD 1.06 billion in its most recent quarterly release, with the period ending within the last few months and therefore falling comfortably inside the current freshness window. The company’s revenue increased by 4.3 percent compared with the same quarter a year earlier, showing mid-single-digit top-line growth in its core dental technology business.MarketBeat
On the bottom line, Align Technology posted earnings per share of USD 2.64 in that quarter, beating the analyst consensus estimate of USD 2.62 by USD 0.02.MarketBeat At the same time, the company achieved a return on equity of 15.86 percent and a net margin of 9.99 percent in that reporting period, underlining that the business is generating double-digit profitability on shareholder capital while maintaining an almost 10 percent net margin in a competitive medical equipment market.MarketBeat
Based on the recent share price of USD 158.63, Align Technology’s market capitalization stands at around USD 11.36 billion, and the stock trades on about 27.59 times earnings on a trailing basis, with a price-to-earnings-growth (PEG) ratio of 1.69.MarketBeat For investors, these valuation metrics place the stock in a premium bracket relative to many diversified medtech peers, but not in an extreme growth multiple territory given the company’s long-established product platform.
Analyst consensus and risk considerations
The latest analyst overview compiled by MarketBeat indicates that Align Technology currently carries a consensus rating of “Moderate Buy” from Wall Street research houses. In detail, one analyst rates the shares as Strong Buy, eight as Buy and six as Hold, reflecting a broadly positive but not euphoric stance on the stock.MarketBeat
Across these ratings, analysts have set an average price objective of USD 206.36 for Align Technology stock, implying upside potential of roughly 30 percent from the recent USD 158.63 quote if the consensus scenario on earnings and growth plays out.MarketBeat Individual targets range from more cautious neutral stances, such as the USD 189.00 objective cited in one recent note, to more optimistic views above USD 200.00 per share, signaling that the market still debates the balance between valuation and growth for the company.MarketBeat
A core risk factor mentioned in the same coverage is the stock’s beta of 1.65, which indicates that Align Technology tends to be more volatile than the overall market.MarketBeat In practical terms, this means that macroeconomic swings, changes in interest rate expectations or broad market sentiment can cause larger moves in Align Technology’s share price than in more defensive healthcare names, even if the company’s underlying Invisalign and digital dentistry business remains steady.
Invisalign and digital dentistry as growth drivers
Align Technology is best known for its Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces and are manufactured using 3D imaging and computer-aided design tools.MarketBeat Since its founding in 1997, the company has expanded its product portfolio to include intraoral scanners, CAD/CAM software for dental laboratories and broader digital dentistry solutions that integrate imaging, treatment planning and appliance production.
The Invisalign platform remains central to Align Technology’s revenue stream, and the company’s 4.3 percent year-over-year revenue increase in the most recent quarter suggests that adoption continues to grow from both orthodontists and general dentists.MarketBeat For investors assessing the long-term story, the key question is whether Align can sustain mid- to high-single-digit growth as clear aligners become a standard treatment option and as it deepens penetration in emerging markets and adult cosmetic dental demand.
Share price level and investor takeaways
As of the latest available quote in early September 2026, Align Technology stock trades at USD 158.63 on Nasdaq, placing it roughly in the middle of its 52-week range between USD 122.00 and USD 200.43.MarketBeat With analysts’ average target at USD 206.36, the stock currently sits below the consensus price level by about USD 47.73 per share, a gap that encapsulates both the perceived growth opportunity and the risks attached to valuation and market volatility.MarketBeat
Align Technology stock key data
- Company: Align Technology, Inc.
- ISIN: US0162551016
- Ticker: ALGN
- Trading venue: Nasdaq
- Price (as of September 8, 2026): 158.63 USD
- Market capitalization: 11.36 billion USD (as of September 8, 2026)
- Sector / Industry: Medical devices / Dental technology
- Index membership: Nasdaq composite
